Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02104817 |
|---|---|
| Brief Title: | Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH) |
| First Submitted : | April 2, 2014 |
| First Submitted that Met QC Criteria : | April 2, 2014 |
| First Posted : | April 4, 2014 (Estimate) |
| Results First Submitted : | May 25, 2021 |
| Results First Submitted that Met QC Criteria : | July 8, 2021 |
| Results First Posted : | July 28, 2021 |
| Last Update Submitted that Met QC Criteria : | August 16, 2021 |
| Last Update Posted : | August 17, 2021 |